Urinary PGDM, a prostaglandin D2 metabolite, is a novel biomarker for objectively detecting allergic reactions of food allergy - 06/11/18
Doi : 10.1016/j.jaci.2018.06.032
Shinichiro Inagaki, MD, PhD a, ∗, Shingo Maeda, DVM, PhD b, ∗, Masami Narita, MD, PhD a, Tatsuro Nakamura, DVM, PhD b, Tatsuo Shimosawa, MD, PhD c, Takahisa Murata, DVM, PhD b 
, Yukihiro Ohya, MD, PhD a
, Yukihiro Ohya, MD, PhD a a Allergy Center, National Center for Child Health and Development, Tokyo, Japan
b Department of Animal Radiology, Graduate School of Agriculture and Life Sciences, University of Tokyo, Tokyo, Japan
c Department of Clinical Laboratory, International University of Health and Welfare, Chiba, Japan
| Supported by a Grant-in-Aid for Scientific Research A form the Japan Society for the Promotion of Science (grant no. 17921666) and Medical Research and Development Programs Focused on Technology Transfers: Development of Advanced Measurement and Analysis Systems from Japan Agency for Medical Research and Development (grant no. 17935758). |
|
| Disclosure of potential conflict of interest: T. Murata has been supported by the Japan Agency for Medical Research and Development (AMED) and the Japan Foundation for Pediatric Research. Y. Ohya has been supported by the AMED during the conduct of the study; grants from AMED; grants and personal fees from the National Center for Child Health and development; grants from the Ministry of Health, Labor and Welfare; grants from the Environmental Restoration and Conservation Agency; grants from the National Institute for Environmental Studies; personal fees from Shiseido; personal fees from Maruho; personal fees from MDD (Merck Sharp and Dohme); personal fees from Kyorin Pharmaceutical; personal fees from Taiho Pharma; personal fees from GlaxoSmithKline: personal fees from Sysmex; personal fees from Kyowa Hakko Kirin; and personal fees from Mitsubishi Tanabe Pharma. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 5
P. 1634 - novembre 2018 Retour au numéro
Article précédent
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Teresa Song, Ana B. Pavel, Huei-Chi Wen, Kunal Malik, Yeriel Estrada, Juana Gonzalez, Peter W. Hashim, John K. Nia, Danielle Baum, Grace Kimmel, Giselle K. Singer, James G. Krueger, Emma Guttman-Yassky
- Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor–associated angioedema
- Scott A. Hubers, Kevin Kohm, Shouzuo Wei, Chang Yu, Hui Nian, Ryan Grabert, Daniel J. Sexton, Nancy J. Brown
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?